The Genetic Basis for Familial Cardiomyopathy in Patients With Idiopathic Cardiomyopathy

This study has been terminated.
(no financial resources were available to complete the study)
Sponsor:
Information provided by (Responsible Party):
Offer Amir, Carmel Medical Center
ClinicalTrials.gov Identifier:
NCT00322582
First received: May 5, 2006
Last updated: January 24, 2012
Last verified: January 2007
  Purpose

In many of the patients with cardiomyopathy, the etiology is not clear . In about 30% there is a family history of cardiomyopathy .Our aim is to study the genetics basis for these patients with cardiomyopathy with no clear etiology and who have a first degree family relative with cardiomyopathy as well.


Condition
Cardiomyopathy

Study Type: Observational
Study Design: Observational Model: Family-Based
Time Perspective: Prospective
Official Title: Open Labeled of the Study the Genetic Basis for Familial Cardiomyopathy in Patients With Idiopathic

Resource links provided by NLM:


Further study details as provided by Carmel Medical Center:

Biospecimen Retention:   Samples With DNA

Blood samples


Enrollment: 41
Study Start Date: May 2007
Study Completion Date: February 2009
Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)
Detailed Description:

A total of 950 blood samples will be collected from patients with idiopathic cardiomyopathy and their relatives and will be analysed for genetics analysis.

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

History of cardiomyopathy

Criteria

Inclusion Criteria:

  • history of cardiomyopathy
  • etiology not known
  • family history of cardiomyopathy
  • ability to understand and sign the informed consent

Exclusion Criteria:

  • refusal to participate
  • pregnancy
  • current participation in another active treatment study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00322582

Locations
Israel
Carmel Medical Center
Haifa, Israel, 34362
Sponsors and Collaborators
Carmel Medical Center
Investigators
Study Director: Offer Amir, MD Lady Davis Carmel Hospital
  More Information

Publications:
Responsible Party: Offer Amir, Offer Amir, MD, Carmel Medical Center, Carmel Medical Center
ClinicalTrials.gov Identifier: NCT00322582     History of Changes
Other Study ID Numbers: GEN/ICM, 136-2005
Study First Received: May 5, 2006
Last Updated: January 24, 2012
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Carmel Medical Center:
familial cardiomyopathy
genetics analysis

Additional relevant MeSH terms:
Cardiomyopathies
Heart Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 26, 2014